• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients.

作者信息

Sebastiani Marco, Manfredi Andreina, Cassone Giulia, Sandri Gilda, Cerri Stefania, Ferri Clodoveo

机构信息

Rheumatology Unit, Azienda Policlinico di Modena, University of Modena and Reggio Emilia, Italy.

Respiratory Disease Unit, Rare Lung Disease Unit (MARP), Azienda Policlinico di Modena, University of Modena and Reggio Emilia, Italy.

出版信息

Clin Exp Rheumatol. 2017 May-Jun;35(3):542. Epub 2017 May 8.

PMID:28516882
Abstract
摘要

相似文献

1
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients.间质性肺病与免疫功能低下的类风湿关节炎患者的下呼吸道感染有关。
Clin Exp Rheumatol. 2017 May-Jun;35(3):542. Epub 2017 May 8.
2
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.堪萨斯分枝杆菌引起的无症状肺部疾病，作为接受那他珠单抗治疗复发缓解型多发性硬化症患者的机会性感染。
Mult Scler. 2014 Apr;20(5):639-40. doi: 10.1177/1352458513501572. Epub 2013 Aug 19.
3
Influence of disease duration and socioeconomic factors on the prevalence of infection and hospitalization in rheumatoid arthritis: KRAC study.疾病持续时间和社会经济因素对类风湿关节炎感染和住院患病率的影响：KRAC 研究。
Int J Rheum Dis. 2019 Jul;22(7):1216-1225. doi: 10.1111/1756-185X.13562. Epub 2019 Apr 11.
4
[Non tuberculous anti-TNF associated opportunistic infections].[非结核性抗 TNF 相关机会性感染]
Rev Med Interne. 2010 May;31(5):353-60. doi: 10.1016/j.revmed.2009.04.010. Epub 2010 Apr 8.
5
Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNFα therapy.类风湿关节炎患者在接受和未接受抗TNFα治疗时的伯氏考克斯体感染（Q热）
Ann Rheum Dis. 2014 Jul;73(7):1436-8. doi: 10.1136/annrheumdis-2014-205455. Epub 2014 May 2.
6
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry.在常规实践中用阿巴西普治疗类风湿关节炎患者的严重感染的预测性风险因素：来自 Orencia 和类风湿关节炎（ORA）登记处的结果。
Ann Rheum Dis. 2016 Jun;75(6):1108-13. doi: 10.1136/annrheumdis-2015-207362. Epub 2015 Jun 5.
7
Risk factors of adverse events during treatment in elderly patients with rheumatoid arthritis: an observational study.老年类风湿关节炎患者治疗期间不良事件的危险因素：一项观察性研究。
Int J Rheum Dis. 2017 Mar;20(3):346-352. doi: 10.1111/1756-185X.12348. Epub 2014 Apr 10.
8
Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan.台湾类风湿性关节炎患者使用病情改善抗风湿生物制剂引发结核病、严重感染及淋巴瘤的风险
Int J Rheum Dis. 2014 Dec;17 Suppl 3:9-19. doi: 10.1111/1756-185X.12539.
9
Infectious respiratory disease in non-HIV immunocompromised patients.非HIV免疫功能低下患者的传染性呼吸道疾病。
Br J Hosp Med (Lond). 2014 Dec;75(12):685-90. doi: 10.12968/hmed.2014.75.12.685.
10
[Infections during antirheumatic treatment].[抗风湿治疗期间的感染]
Dtsch Med Wochenschr. 2014 Aug;139(31-32):1593-5. doi: 10.1055/s-0034-1370205. Epub 2014 Jul 30.

引用本文的文献

1
[Pulmonary manifestations of rheumatoid arthritis, a review in SARS-CoV-2 pandemia].[类风湿关节炎的肺部表现，SARS-CoV-2大流行期间的综述]
Rev Colomb Reumatol. 2022 Jun;29:S56-S65. doi: 10.1016/j.rcreu.2020.12.005. Epub 2021 Mar 5.
2
Rate of severe and fatal infections in a cohort of patients with interstitial lung disease associated with rheumatoid arthritis: a multicenter prospective study.类风湿关节炎相关间质性肺疾病患者队列中严重和致命感染的发生率：一项多中心前瞻性研究。
Front Immunol. 2024 Mar 28;15:1341321. doi: 10.3389/fimmu.2024.1341321. eCollection 2024.
3
Personalized Medicine and Machine Learning: A Roadmap for the Future.
个性化医疗与机器学习：未来路线图
J Clin Med. 2022 Jul 15;11(14):4110. doi: 10.3390/jcm11144110.
4
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.托法替布用于治疗类风湿关节炎相关的重症间质性肺疾病。
Case Rep Med. 2021 Apr 22;2021:6652845. doi: 10.1155/2021/6652845. eCollection 2021.
5
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.霉酚酸酯治疗风湿性疾病相关间质性肺疾病的疗效与安全性：一项叙述性综述
Drugs Context. 2021 Jan 15;10. doi: 10.7573/dic.2020-8-8. eCollection 2021.
6
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.风湿病学中使用的生物制剂的安全性概况：一项意大利前瞻性药物警戒研究。
J Clin Med. 2020 Apr 24;9(4):1227. doi: 10.3390/jcm9041227.
7
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.类风湿关节炎相关间质性肺疾病的治疗：光明与阴影
J Clin Med. 2020 Apr 10;9(4):1082. doi: 10.3390/jcm9041082.
8
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.阿巴西普在意大利类风湿关节炎合并间质性肺疾病患者中的安全性：一项多中心回顾性研究。
J Clin Med. 2020 Jan 19;9(1):277. doi: 10.3390/jcm9010277.